Studies of critically ill patients with COVID-19 show that fewer patients died and less ICU support was required when patients received corticosteroids.
A phase 3 clinical trial has shown that a new drug boosts bone growth in children born with achondroplasia — the most common type of dwarfism.
Biotech company CSL has signed two separate heads of agreement (HoA) for COVID-19 vaccines should clinical trials prove successful.
Venom from honeybees has been found to induce cancer cell death in hard-to-treat triple-negative breast cancer, with minimal effect on healthy cells.
The NanoAssemblr platform from Precision Nanosystems enables the rapid, reproducible and scalable manufacture of next-generation nanoparticle formulations such as lipid nanoparticles and liposomes to encapsulate a payload such as a SAM.
The company has been launched in Queensland to help accelerate the development and commercialisation of Australian-born medical devices for the global market.
The formation of 'micropores' underneath the skin allows drugs applied on the surface to diffuse through it more easily.
The drugs work through a mechanism that is distinct from currently prescribed medicines for asthma and chronic obstructive pulmonary disease.
The Australian Government has reached a deal that would see the University of Oxford's COVID-19 vaccine made available to all Australians for free.
Researchers have compiled a list of 57 medications that may not function as intended when used with medical cannabinoids, CBD oil or marijuana.
A newly developed drug candidate has successfully reversed memory loss in a mouse model of inherited Alzheimer's disease.
Russian President Valdimir Putin has announced that his country has become the first in the world to grant regulatory approval to a COVID-19 vaccine.
The malaria drug chloroquine, demonstrated to inhibit SARS-CoV-2 infection of African green monkey kidney cells, is not able to prevent infection of human lung cells.
The nanoparticles were engineered to only release their drug content upon a specific cue which is present in the tumour area.
Curcumin, a natural compound found in the spice turmeric, can prevent transmissible gastroenteritis virus (TGEV) from infecting cells in pigs.